Wall Street analysts expect that Aquabounty Technologies Inc (NASDAQ:AQB) will announce $140,000.00 in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Aquabounty Technologies’ earnings. The highest sales estimate is $260,000.00 and the lowest is $20,000.00. The firm is scheduled to report its next quarterly earnings report on Thursday, November 1st.
On average, analysts expect that Aquabounty Technologies will report full-year sales of $480,000.00 for the current fiscal year, with estimates ranging from $110,000.00 to $850,000.00. For the next financial year, analysts forecast that the business will post sales of $1.11 million, with estimates ranging from $600,000.00 to $1.62 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Aquabounty Technologies.
Aquabounty Technologies (NASDAQ:AQB) last announced its quarterly earnings data on Tuesday, August 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.03). The firm had revenue of $0.05 million for the quarter, compared to analysts’ expectations of $0.02 million.
An institutional investor recently raised its position in Aquabounty Technologies stock. ARK Investment Management LLC raised its holdings in Aquabounty Technologies Inc (NASDAQ:AQB) by 81.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 170,697 shares of the company’s stock after purchasing an additional 76,458 shares during the quarter. ARK Investment Management LLC owned 1.33% of Aquabounty Technologies worth $568,000 at the end of the most recent reporting period. 62.42% of the stock is owned by hedge funds and other institutional investors.
Shares of AQB opened at $3.34 on Friday. The firm has a market cap of $41.24 million, a PE ratio of -3.15 and a beta of -2.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.30 and a current ratio of 3.36. Aquabounty Technologies has a 1-year low of $2.25 and a 1-year high of $9.99.
Aquabounty Technologies Company Profile
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
See Also: Ex-Dividend
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.